25 February 2021
The Research Committee, on behalf of the ALA Board, is again calling for applications for research grants to support a key objective of the ALA:
'Encourage and support lymphoedema research and curate research on behalf of members'
The ALA is offering up to three research grants, between $5,000 and $10,000 (maximum grant funding available $20,000). The grants will be awarded on merit with applications limited to early career researchers (ECR) - see eligibility criteria in main article. Applications close Wednesday 31 March, 2021 5:00pm (AEDT). Successful applicants will be announced at the ALA Symposium, 14-16 May on the Gold Coast.
24 February 2021
Early Bird registration closes 10 March 2021
*Places in many breakfast sessions and concurrent sessions are strictly limited, so don't delay, register today!
Read More19 February 2021
In line with the ALA's Constitution, nominations are now open and must close at 5.00pm AEDT on Friday 19 March 2021
22 October 2018
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR),today announced Phase 2 ULTRA study results in primary and secondary lymphedema of the lower limb demonstrated no improvement of ubenimex over placebo in the primary endpoint of skin thickness and secondary endpoints of limb volume and bioimpedance. No safety signals attributed to ubenimex were identified.
Read More20 June 2018
In response to the State of the Nation report released by Breast Cancer Network of Australia on Wednesday 20 June, the Minister for Health, the Hon. Greg Hunt on behalf of the Australian Federal Government announced three commitments including: To work with state and territory governments to improve access to lymphoedema compression garment subsidies and create a national standard.
Read More19 March 2018
On Sunday 18 March 2018, the 3AW radio program 'Talking Health' with Dr Sally Cockburn focused their entire two hour broadcast to talking about lymphoedema. For those who were unable to listen to the broadcast, the podcast is now available.
Read More30 October 2017
Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up Ana Carolina Padula Ribeiro Pereira; Rosalina Jorge Koifman; Anke Bergmann
Highlights •We followed a cohort of women surgically treated for breast cancer for 10 years. •Incidence of lymphedema increases from 13.5% in two years to 41.1% in ten years. •Radiotherapy, obesity, seroma, chemotherapy and stage were associated variables.
01 October 2017
The ALA was excited to launch the Living with Lymphoedema Australia and New Zealand Facebook group at the recent Advisory Forum. This group is unmoderated and its purpose is to maintain connection with consumers throughout Australia and New Zealand.
01 September 2017
Minister agrees that SA needs a Garment Scheme - Equity Update
The ALA has received a response from Jack Snelling, South Australian Minister for Health following on from recent meetings and representation made in regards to establishing a compression garment scheme in South Australia.
The Minister agreed that it would be beneficial for the State Government to provide a garment subsidy scheme for eligible lymphoedema sufferers and that, while the funding does not currently exist, a full business case will be prepared with a view to securing funding for the scheme as part of the 2018-19 State Government budget process.
Congratulations to the team who have been involved in this advocacy - Margie McConachy, Karin Stepputtis and Monique Bareham.
The Australasian Lymphology Association (ALA) is committed to promoting the development of lymphology in Australasia. The Association will strive to improve the management of those with, or at risk of developing lymphoedema and enhance communication between health professionals, educators, relevant authorities and government in regard to oedemas and lymphoedema.
